Nakase T, Tatewaki Y, Takano Y, Nomura S, Baek H, Taki Y
Int J Mol Sci. 2025; 26(5).
PMID: 40076944
PMC: 11899992.
DOI: 10.3390/ijms26052325.
Leuchter M, Oughli H, Durbin K, Jackson N, Elashoff D, Chang T
Alzheimers Dement (N Y). 2025; 11(1):e70043.
PMID: 40065917
PMC: 11891574.
DOI: 10.1002/trc2.70043.
Wood Alexander M, Honer W, Saloner R, Galea L, Bennett D, Rabin J
Sci Adv. 2025; 11(10):eadt0757.
PMID: 40043118
PMC: 11881898.
DOI: 10.1126/sciadv.adt0757.
Dickstein D, Zhang R, Ru N, Vozenin M, Perry B, Wang J
Brain Struct Funct. 2025; 230(2):41.
PMID: 40024988
PMC: 11872753.
DOI: 10.1007/s00429-025-02902-y.
Lee A, Howard E, Saltiel N, Hayes J, Hayes S
Brain Commun. 2025; 7(1):fcaf068.
PMID: 39995657
PMC: 11848269.
DOI: 10.1093/braincomms/fcaf068.
Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease.
Wright A, Weible A, Estes O, Wehr M
Front Aging Neurosci. 2025; 17:1505908.
PMID: 39963471
PMC: 11830726.
DOI: 10.3389/fnagi.2025.1505908.
AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.
Choquet D, Opazo P, Zhang H
Transl Neurodegener. 2025; 14(1):8.
PMID: 39934896
PMC: 11817889.
DOI: 10.1186/s40035-025-00470-z.
Distinct disruptions in CA1 and CA3 place cell function in Alzheimer's disease mice.
Park S, Park M, Kim E, Kim J, Cho J, Huh Y
iScience. 2025; 28(2):111631.
PMID: 39911347
PMC: 11795144.
DOI: 10.1016/j.isci.2024.111631.
Hippocampal neuronal loss and cognitive decline in LATE-NC and ADNC among community-dwelling older persons.
Agrawal S, Yu L, Leurgans S, Nag S, Barnes L, Bennett D
Alzheimers Dement. 2025; 21(2):e14500.
PMID: 39888320
PMC: 11851160.
DOI: 10.1002/alz.14500.
Alzheimer's disease: an integrative bioinformatics and machine learning analysis reveals glutamine metabolism-associated gene biomarkers.
Xing N, Yan J, Gao R, Zhang A, He H, Zheng M
BMC Pharmacol Toxicol. 2025; 26(1):19.
PMID: 39875978
PMC: 11776333.
DOI: 10.1186/s40360-025-00852-z.
Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.
He S, Xu Z, Han X
Mol Neurodegener. 2025; 20(1):11.
PMID: 39871348
PMC: 11773937.
DOI: 10.1186/s13024-025-00803-6.
Dendritic alterations precede age-related dysphagia and nucleus ambiguus motor neuron death.
Fogarty M
J Physiol. 2025; 603(5):1299-1321.
PMID: 39868939
PMC: 11870054.
DOI: 10.1113/JP287457.
VDAC1: A Key Player in the Mitochondrial Landscape of Neurodegeneration.
Argueti-Ostrovsky S, Barel S, Kahn J, Israelson A
Biomolecules. 2025; 15(1).
PMID: 39858428
PMC: 11762377.
DOI: 10.3390/biom15010033.
Revealing excitation-inhibition imbalance in Alzheimer's disease using multiscale neural model inversion of resting-state functional MRI.
Li G, Hsu L, Wu Y, Bozoki A, Shih Y, Yap P
Commun Med (Lond). 2025; 5(1):17.
PMID: 39814858
PMC: 11735810.
DOI: 10.1038/s43856-025-00736-7.
Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease.
Maisto N, Mango D
J Pharm Anal. 2025; 14(12):101057.
PMID: 39802402
PMC: 11718335.
DOI: 10.1016/j.jpha.2024.101057.
Amyloid-β-Driven Synaptic Deficits Are Mediated by Synaptic Removal of GluA3-Containing AMPA Receptors.
Reinders N, van der Spek S, Klaassen R, Koymans K, MacGillavry H, Smit A
J Neurosci. 2025; 45(9).
PMID: 39779375
PMC: 11867010.
DOI: 10.1523/JNEUROSCI.0393-24.2024.
Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.
Yanai H, Adachi H, Hakoshima M, Katsuyama H
Molecules. 2025; 29(24.
PMID: 39770025
PMC: 11677283.
DOI: 10.3390/molecules29245936.
Therapeutic Options in Alzheimer's Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity.
Cacabelos R, Martinez-Iglesias O, Cacabelos N, Carrera I, Corzo L, Naidoo V
Life (Basel). 2025; 14(12.
PMID: 39768263
PMC: 11678002.
DOI: 10.3390/life14121555.
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease.
Van Eldik L, Siemers E, Collins E, Gold M, Henley D, Johannsen P
Alzheimers Dement (N Y). 2025; 10(4):e70014.
PMID: 39748839
PMC: 11694522.
DOI: 10.1002/trc2.70014.
Localized molecular chaperone synthesis maintains neuronal dendrite proteostasis.
Alecki C, Rizwan J, Le P, Jacob-Tomas S, Comaduran M, Verbrugghe M
Nat Commun. 2024; 15(1):10796.
PMID: 39737952
PMC: 11685665.
DOI: 10.1038/s41467-024-55055-7.